Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Virtus Investment Partners
VRTS
$1.14B
| $1.45M | ﹤0.01% |
12,706
+4,810
| +61% | +$611K |
|
3227
PUT
United Therapeutics
UTHR
$21.5B
| $1.45M | ﹤0.01% |
11,300
+300
| +3% | +$37.1K |
|
3228
Chegg
CHGG
$89.3M
| $1.44M | ﹤0.01% |
50,718
+40,136
| +379% | +$1.2M |
|
|
BPFH
3229
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.44M | ﹤0.01% |
105,728
+59,522
| +129% | +$870K |
|
|
VSI
3230
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.44M | ﹤0.01% |
144,210
-22,153
| -13% | -$229K |
|
3231
CALL
EQT Corp
EQT
$33.8B
| $1.44M | ﹤0.01% |
59,703
-246,158
| -80% | -$6.79M |
|
3232
Invesco DB Agriculture Fund
DBA
$1.23B
| $1.44M | ﹤0.01% |
84,892
-162,563
| -66% | -$2.81M |
|
|
NXGN
3233
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.43M | ﹤0.01% |
71,356
+41,810
| +142% | +$886K |
|
3234
Innoviva
INVA
$1.5B
| $1.43M | ﹤0.01% |
93,867
+28,141
| +43% | +$405K |
|
3235
CVR Energy
CVI
$3.58B
| $1.43M | ﹤0.01% |
35,550
+24,813
| +231% | +$932K |
|
|
MCRN
3236
DELISTED
Milacron Holdings Corp.
MCRN
| $1.43M | ﹤0.01% |
70,472
+44,989
| +177% | +$911K |
|
|
MODV
3237
DELISTED
ModivCare
MODV
| $1.42M | ﹤0.01% |
21,165
+5,002
| +31% | +$347K |
|
3238
Team
TISI
$101M
| $1.42M | ﹤0.01% |
6,316
+4,337
| +219% | +$981K |
|
|
ACIA
3239
DELISTED
Acacia Communications Inc
ACIA
| $1.42M | ﹤0.01% |
34,293
-15,442
| -31% | -$577K |
|
|
PGTI
3240
DELISTED
PGT, Inc.
PGTI
| $1.41M | ﹤0.01% |
65,350
+32,190
| +97% | +$752K |
|
|
CERN
3241
CALL
DELISTED
Cerner Corp
CERN
| $1.41M | ﹤0.01% |
21,900
-10,600
| -33% | -$674K |
|
3242
CALL
Itaú Unibanco
ITUB
$80.9B
| $1.41M | ﹤0.01% |
264,490
+111,115
| +72% | +$597K |
|
3243
CTS Corp
CTS
$1.79B
| $1.41M | ﹤0.01% |
41,039
+28,860
| +237% | +$1.04M |
|
3244
Movado Group
MOV
$796M
| $1.41M | ﹤0.01% |
33,593
+19,526
| +139% | +$915K |
|
|
ESIO
3245
DELISTED
Electro Scientific Industries
ESIO
| $1.41M | ﹤0.01% |
80,634
+51,000
| +172% | +$994K |
|
3246
Century Aluminum
CENX
$4.59B
| $1.41M | ﹤0.01% |
117,488
+60,303
| +105% | +$776K |
|
3247
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $1.4M | ﹤0.01% |
16,876
+2,343
| +16% | +$195K |
|
|
NUAN
3248
DELISTED
Nuance Communications, Inc.
NUAN
| $1.4M | ﹤0.01% |
93,309
-6,224
| -6% | -$86.3K |
|
3249
Interparfums
IPAR
$3.7B
| $1.4M | ﹤0.01% |
21,680
+14,223
| +191% | +$873K |
|
3250
Universal Display
OLED
$4.18B
| $1.4M | ﹤0.01% |
11,848
-79,710
| -87% | -$8.76M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.